Correlation Between KIOCL and Aarti Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both KIOCL and Aarti Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining KIOCL and Aarti Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between KIOCL Limited and Aarti Drugs Limited, you can compare the effects of market volatilities on KIOCL and Aarti Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in KIOCL with a short position of Aarti Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of KIOCL and Aarti Drugs.

Diversification Opportunities for KIOCL and Aarti Drugs

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between KIOCL and Aarti is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding KIOCL Limited and Aarti Drugs Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aarti Drugs Limited and KIOCL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on KIOCL Limited are associated (or correlated) with Aarti Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aarti Drugs Limited has no effect on the direction of KIOCL i.e., KIOCL and Aarti Drugs go up and down completely randomly.

Pair Corralation between KIOCL and Aarti Drugs

Assuming the 90 days trading horizon KIOCL Limited is expected to generate 1.4 times more return on investment than Aarti Drugs. However, KIOCL is 1.4 times more volatile than Aarti Drugs Limited. It trades about 0.08 of its potential returns per unit of risk. Aarti Drugs Limited is currently generating about 0.01 per unit of risk. If you would invest  37,700  in KIOCL Limited on October 6, 2024 and sell it today you would earn a total of  2,060  from holding KIOCL Limited or generate 5.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

KIOCL Limited  vs.  Aarti Drugs Limited

 Performance 
       Timeline  
KIOCL Limited 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in KIOCL Limited are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, KIOCL displayed solid returns over the last few months and may actually be approaching a breakup point.
Aarti Drugs Limited 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aarti Drugs Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest uncertain performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

KIOCL and Aarti Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with KIOCL and Aarti Drugs

The main advantage of trading using opposite KIOCL and Aarti Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if KIOCL position performs unexpectedly, Aarti Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aarti Drugs will offset losses from the drop in Aarti Drugs' long position.
The idea behind KIOCL Limited and Aarti Drugs Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals